ORMP — Oramed Pharmaceuticals Inc.

$4.44-0.89%

B-

Dividend Yield5.63%

Annual Dividend$0.25

Payout Ratio

N/A

Consecutive Years0 yrs

FrequencyN/A

Next Ex-Date

N/A

View full dividend history →

Dividend Grades

vs Healthcare sector

B-

Overall

Yield

N/AGrowth

N/ASafety

Consistency

A+

Performance

Metric	ORMP	Sector Median	Percentile
Dividend Yield	5.63%	1.67%	84th
Dividend Growth (5Y)	—	6.20%	—
Payout Ratio	—	32.4%	—
Consecutive Years Paid	1	15	7th
1Y Total Return	+89.6%	4.5%	92th

Grades compare this stock to Healthcare sector peers using percentile ranks. A+ = top 10%, F = bottom 10%. See methodology →

1-Year Growth

N/A

3-Year Growth

N/A

5-Year Growth

N/A

10-Year Growth

N/A

Key Dividend Dates

Next Ex-Date

N/A

Next Payment

N/A

Last Ex-Date

Jan 16, 2026

Last Payment

Jan 26, 2026

Dividend History

Ex-Date	Payment Date	Amount	Type	Change
Jan 16, 2026	Jan 26, 2026	$0.2500	Cash	N/A

Payout Ratio (Earnings)

N/A

FCF Payout Ratio

N/A

Peer Comparison

Symbol	Company	Yield	Payout	Years	Growth 5Y	Market Cap
REGN	Regeneron Pharmaceuticals, Inc.	0.51%	9.00%	0	N/A	$81.19B
TECH	Bio-Techne Corporation	0.55%	78.40%	0	0.00%	$11.35B
CNTA	Centessa Pharmaceuticals plc	93.84%	N/A	0	N/A	$3.51B
ATAI	Atai Beckley Inc.	92.02%	N/A	1	N/A	$2.70B
ESPR	Esperion Therapeutics, Inc.	99.37%	N/A	0	N/A	$661M

Compare ORMP:

ORMP vs REGN ORMP vs TECH ORMP vs CNTA ORMP vs ATAI

About this data

Dividend data sourced from Financial Modeling Prep. Prices updated daily after market close.

Payout ratio — trailing 12-month dividends paid / trailing 12-month net income.

Consecutive years — calendar years with a higher total annual dividend than the prior year.

Growth rates — annualized, comparing the most recent full year total to the total N years prior.

For informational purposes only. Not investment advice.

Data as of October 3, 2026. Source: Financial Modeling Prep. Prices and yields updated daily after market close.